TY - JOUR
T1 - Start of the 2014/15 influenza season in Europe
T2 - Drifted influenza A(H3N2) viruses circulate as dominant subtype
AU - WHO European Region and the European Influenza Surveillance Network
AU - Broberg, E.
AU - Snacken, R.
AU - Adlhoch, C.
AU - Beauté, J.
AU - Galinska, M.
AU - Pereyaslov, D.
AU - Brown, C.
AU - Penttinen, P.
AU - Kota, Majlinda
AU - Simaku, Artan
AU - Sarkisian, Shushan
AU - Torosyan, Liana
AU - Popow-Kraupp, Therese
AU - Rendi-Wagner, Pamela
AU - Schmid, Daniela
AU - Abdullayeva, Nazakat
AU - Salimov, Oleg
AU - Gribkova, Natalia
AU - Shimanovich, Veronika
AU - Thomas, Isabelle
AU - Hombrouck, Anneleen
AU - Bossuyt, Nathalie
AU - Moreels, Sarah
AU - Van Casteren, Viviane
AU - Ljubovic, Amela Dedejic
AU - Rodic, Nina Vukmir
AU - Korsun, Neli
AU - Kojouharova, Mira
AU - Georgieva, Teodora
AU - Drazenovic, Vladimir
AU - Bagatzouni, Despo
AU - Koliou, Maria
AU - Havlickova, Martina
AU - Jiřincová, Helena
AU - Kyncl, Jan
AU - Knudsen, Lisbet Krause
AU - Mazick, Anne
AU - Trebbien, Ramona
AU - Fischer, Thea Kølsen
AU - Lilje, Liisa
AU - Pokras, Lesja
AU - Kuznetsova, Natalja
AU - Sadikova, Olga
AU - Ikonen, Niina
AU - Lyytikäinen, Outi
AU - Green, Helen
AU - Zambon, Maria
AU - Nugent, Christopher
AU - Phin, Nick
AU - Pebody, Richard
N1 - Publisher Copyright:
© 2015, European Centre for Disease Prevention and Control (ECDC). All Rights Reserved.
PY - 2015
Y1 - 2015
N2 - The influenza season 2014/15 started in Europe in week 50 2014 with influenza A(H3N2) viruses predominating. The majority of the A(H3N2) viruses characterised antigenically and/or genetically differ from the northern hemisphere vaccine component which may result in reduced vaccine effectiveness for the season. We therefore anticipate that this season may be more severe than the 2013/14 season. Treating influenza with antivirals in addition to prevention with vaccination will be important.
AB - The influenza season 2014/15 started in Europe in week 50 2014 with influenza A(H3N2) viruses predominating. The majority of the A(H3N2) viruses characterised antigenically and/or genetically differ from the northern hemisphere vaccine component which may result in reduced vaccine effectiveness for the season. We therefore anticipate that this season may be more severe than the 2013/14 season. Treating influenza with antivirals in addition to prevention with vaccination will be important.
UR - https://www.scopus.com/pages/publications/84979941589
U2 - 10.2807/1560-7917.ES2015.20.4.21023
DO - 10.2807/1560-7917.ES2015.20.4.21023
M3 - Article
C2 - 25655052
AN - SCOPUS:84979941589
SN - 1025-496X
VL - 20
JO - Eurosurveillance
JF - Eurosurveillance
IS - 4
M1 - 21023
ER -
SDG 3 Good Health and Well-being